Sonpavde, Guru <br/><br/>
Improving the Cost Efficiency of PD-1/PD-L1 Inhibitors for Advanced Urothelial Carcinoma: A Major Role for Precision Medicine?  [electronic resource] 

 -  European urology  07 2018 
 - 63-65 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1873-7560 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2018.03.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized<br/>B7-H1 Antigen<br/>Cost-Benefit Analysis<br/>Humans<br/>Precision Medicine<br/>Programmed Cell Death 1 Receptor<br/>Urinary Bladder Neoplasms